Vivos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $8.4M | $25.3M | $18.2M |
| FY2021 | $8.2M | $33.7M | $24.0M |
| FY2022 | $8.9M | $13.7M | $3.5M |
| FY2023 | $10.3M | $10.7M | $1.6M |
| FY2024 | $7.3M | $15.3M | $6.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $8.4M | $25.3M | $18.2M |
| FY2021 | $8.2M | $33.7M | $24.0M |
| FY2022 | $8.9M | $13.7M | $3.5M |
| FY2023 | $10.3M | $10.7M | $1.6M |
| FY2024 | $7.3M | $15.3M | $6.3M |